Greg Lemke, Carla V Rothlin. Nat Rev Immunol 2008
Times Cited: 563
Times Cited: 563
Douglas K Graham, Deborah DeRyckere, Kurtis D Davies, H Shelton Earp. Nat Rev Cancer 2014
Times Cited: 413
Times Cited: 413
List of shared articles
Times cited
Bevacizumab and anexelekto inhibitor, TP-0903 inhibits TGF-β1-induced epithelial-mesenchymal transition of colon cancer cells.
Se-Hee Kim, Sangtae Choi, Won-Suk Lee. Anticancer Drugs 2022
Se-Hee Kim, Sangtae Choi, Won-Suk Lee. Anticancer Drugs 2022
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.
Neeraj Agarwal, Arun Azad, Joan Carles, Simon Chowdhury, Bradley McGregor, Axel S Merseburger, Stéphane Oudard, Fred Saad, Andrey Soares, Fawzi Benzaghou,[...]. Future Oncol 2022
Neeraj Agarwal, Arun Azad, Joan Carles, Simon Chowdhury, Bradley McGregor, Axel S Merseburger, Stéphane Oudard, Fred Saad, Andrey Soares, Fawzi Benzaghou,[...]. Future Oncol 2022
Drugging the efferocytosis process: concepts and opportunities.
Parul Mehrotra, Kodi S Ravichandran. Nat Rev Drug Discov 2022
Parul Mehrotra, Kodi S Ravichandran. Nat Rev Drug Discov 2022
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.
Solange Peters, Luis Paz-Ares, Roy S Herbst, Martin Reck. J Immunother Cancer 2022
Solange Peters, Luis Paz-Ares, Roy S Herbst, Martin Reck. J Immunother Cancer 2022
The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages.
Lidia Jiménez-García, Christopher Mayer, Patrick G Burrola, Youtong Huang, Maxim N Shokhirev, Greg Lemke. Front Immunol 2022
Lidia Jiménez-García, Christopher Mayer, Patrick G Burrola, Youtong Huang, Maxim N Shokhirev, Greg Lemke. Front Immunol 2022
AXL kinase inhibitors- A prospective model for medicinal chemistry strategies in anticancer drug discovery.
Chinmay Malvankar, Dileep Kumar. Biochim Biophys Acta Rev Cancer 2022
Chinmay Malvankar, Dileep Kumar. Biochim Biophys Acta Rev Cancer 2022
Immunotherapy of targeting MDSCs in tumor microenvironment.
Hongshu Sui, Shengyi Dongye, Xiaocui Liu, Xinghua Xu, Li Wang, Christopher Q Jin, Minhua Yao, Zhaoqing Gong, Daniel Jiang, Kexin Zhang,[...]. Front Immunol 2022
Hongshu Sui, Shengyi Dongye, Xiaocui Liu, Xinghua Xu, Li Wang, Christopher Q Jin, Minhua Yao, Zhaoqing Gong, Daniel Jiang, Kexin Zhang,[...]. Front Immunol 2022
The role of phosphatidylserine on the membrane in immunity and blood coagulation.
Jiao Wang, Changxin Yu, Junyi Zhuang, Wenxin Qi, Jiawen Jiang, Xuanting Liu, Wanwei Zhao, Yiyang Cao, Hao Wu, Jingxuan Qi,[...]. Biomark Res 2022
Jiao Wang, Changxin Yu, Junyi Zhuang, Wenxin Qi, Jiawen Jiang, Xuanting Liu, Wanwei Zhao, Yiyang Cao, Hao Wu, Jingxuan Qi,[...]. Biomark Res 2022
The role of macrophage TAM receptor family in the acute-to-chronic progression of liver disease: From friend to foe?
Haitao Huang, Jingyu Jiang, Ruihan Chen, Yimou Lin, Hui Chen, Qi Ling. Liver Int 2022
Haitao Huang, Jingyu Jiang, Ruihan Chen, Yimou Lin, Hui Chen, Qi Ling. Liver Int 2022
TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment?
Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, Suvajit Sen, Nizar M Tannir. Expert Opin Ther Targets 2021
Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, Suvajit Sen, Nizar M Tannir. Expert Opin Ther Targets 2021
MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
Chao-Ju Chen, Yu-Peng Liu. Pharmaceuticals (Basel) 2021
Chao-Ju Chen, Yu-Peng Liu. Pharmaceuticals (Basel) 2021
TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Pia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, Anne Rahbech, Per Thor Straten. Cancers (Basel) 2021
Pia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, Anne Rahbech, Per Thor Straten. Cancers (Basel) 2021
Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10.
Avi Maimon, Victor Levi-Yahid, Kerem Ben-Meir, Amit Halpern, Ziv Talmi, Shivam Priya, Gabriel Mizraji, Shani Mistriel-Zerbib, Michael Berger, Michal Baniyash,[...]. J Clin Invest 2021
Avi Maimon, Victor Levi-Yahid, Kerem Ben-Meir, Amit Halpern, Ziv Talmi, Shivam Priya, Gabriel Mizraji, Shani Mistriel-Zerbib, Michael Berger, Michal Baniyash,[...]. J Clin Invest 2021
AXL, an Important Host Factor for DENV and ZIKV Replication.
Shengda Xie, Huiru Zhang, Zhenjie Liang, Xingmiao Yang, Ruibing Cao. Front Cell Infect Microbiol 2021
Shengda Xie, Huiru Zhang, Zhenjie Liang, Xingmiao Yang, Ruibing Cao. Front Cell Infect Microbiol 2021
The complex roles of efferocytosis in cancer development, metastasis, and treatment.
Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Ahmad Movahedpour, Amir Savardashtaki, Reid Loveless, George E Barreto, Yong Teng, Amirhossein Sahebkar. Biomed Pharmacother 2021
Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Ahmad Movahedpour, Amir Savardashtaki, Reid Loveless, George E Barreto, Yong Teng, Amirhossein Sahebkar. Biomed Pharmacother 2021
Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment.
Liwen Zhou, Glenn K Matsushima. Int Rev Cell Mol Biol 2021
Liwen Zhou, Glenn K Matsushima. Int Rev Cell Mol Biol 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, Swathi Veeroju, Isabel Ben-Batalla, Paola Caruso, Mazen Shihan, Nadine Presser, Elsa Götz, Carina Lepper,[...]. Commun Biol 2021
Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, Swathi Veeroju, Isabel Ben-Batalla, Paola Caruso, Mazen Shihan, Nadine Presser, Elsa Götz, Carina Lepper,[...]. Commun Biol 2021
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.
Viola Hedrich, Kristina Breitenecker, Leila Djerlek, Gregor Ortmayr, Wolfgang Mikulits. Cancers (Basel) 2021
Viola Hedrich, Kristina Breitenecker, Leila Djerlek, Gregor Ortmayr, Wolfgang Mikulits. Cancers (Basel) 2021
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Anna Tutusaus, Estefanía de Gregorio, Blanca Cucarull, Helena Cristóbal, Cristina Aresté, Isabel Graupera, Mar Coll, Anna Colell, Gro Gausdal, James B Lorens,[...]. Cell Mol Gastroenterol Hepatol 2020
Anna Tutusaus, Estefanía de Gregorio, Blanca Cucarull, Helena Cristóbal, Cristina Aresté, Isabel Graupera, Mar Coll, Anna Colell, Gro Gausdal, James B Lorens,[...]. Cell Mol Gastroenterol Hepatol 2020
Identification of pAKT as a pharmacodynamic marker for MER kinase in human melanoma G361 cells.
Yaoyu Chen, Margaret Favata, Michelle Pusey, Jun Li, Yvonne Lo, Min Ye, Richard Wynn, Xiaozhao Wang, Wenqing Yao, Yingnan Chen. Biomark Res 2020
Yaoyu Chen, Margaret Favata, Michelle Pusey, Jun Li, Yvonne Lo, Min Ye, Richard Wynn, Xiaozhao Wang, Wenqing Yao, Yingnan Chen. Biomark Res 2020
Gas6 negatively regulates the Staphylococcus aureus-induced inflammatory response via TLR signaling in the mouse mammary gland.
Arshad Zahoor, Yaping Yang, Chao Yang, Muhammad Akhtar, Yingfang Guo, Aftab Shaukat, Meng-Yao Guo, Ganzhen Deng. J Cell Physiol 2020
Arshad Zahoor, Yaping Yang, Chao Yang, Muhammad Akhtar, Yingfang Guo, Aftab Shaukat, Meng-Yao Guo, Ganzhen Deng. J Cell Physiol 2020
Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance.
Veronica Mendoza-Reinoso, Dah Youn Baek, Adrianne Kurutz, John R Rubin, Amy J Koh, Laurie K McCauley, Hernan Roca. Cells 2020
Veronica Mendoza-Reinoso, Dah Youn Baek, Adrianne Kurutz, John R Rubin, Amy J Koh, Laurie K McCauley, Hernan Roca. Cells 2020
TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.
Adam S Dayoub, Rolf A Brekken. Cell Commun Signal 2020
Adam S Dayoub, Rolf A Brekken. Cell Commun Signal 2020